| 000 | 01796 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517213659.0 | ||
| 264 | 0 | _c20180611 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1178-2013 | ||
| 024 | 7 |
_a10.2147/IJN.S160848 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTong, Fei | |
| 245 | 0 | 0 |
_aEndogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus. _h[electronic resource] |
| 260 |
_bInternational journal of nanomedicine _c2018 |
||
| 300 |
_a2507-2520 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Retracted Publication | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aChitosan _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCoronary Vessels _xphysiopathology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 |
_aIschemic Preconditioning, Myocardial _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xpathology |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xdrug therapy |
| 650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
| 650 | 0 | 4 |
_aOrnithine Decarboxylase _xmetabolism |
| 650 | 0 | 4 |
_aPolyamines _xmetabolism |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aLiu, Suhuan | |
| 700 | 1 | _aYan, Bing | |
| 700 | 1 | _aLi, Xuejun | |
| 700 | 1 | _aRuan, Shiwei | |
| 700 | 1 | _aYang, Shuyu | |
| 773 | 0 |
_tInternational journal of nanomedicine _gvol. 13 _gp. 2507-2520 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/IJN.S160848 _zAvailable from publisher's website |
| 999 |
_c28350126 _d28350126 |
||